HIV/AIDS, Comorbidity, and Alcohol: Can We Make a Difference?

por Justice, Amy, Sullivan, Lynn, Fiellin, David
Publicado 2010

A Case of Kratom Use: Implications for Managing Addiction and Addressing Comorbidity in Overdose Survivors, and for the Education of Clinicians Who Are Not Addiction Specialists

por Donroe, Joseph H., Fiellin, David A.
Publicado 2022

Bridging the Gap: Dual Fellowship Training in Addiction Medicine and Digestive Diseases

por Haque, Lamia Y., Fiellin, David A.
Publicado 2022

Opioid substitution treatment is linked to reduced risk of death in opioid use disorder

por Manhapra, Ajay, Rosenheck, Robert, Fiellin, David A
Publicado 2017

3575 Assessing Research Activity and Capacity of Community Based Organizations: Field Testing of the Community Research Activity Assessment Tool (CREAT)

por Walker, Mahaya Allie, Ray, Natasha, Fiellin, David, Humphries, Debbie
Publicado 2019

Trends in the Use of Buprenorphine in US Emergency Departments, 2002-2017

por Rhee, Taeho Greg, D’Onofrio, Gail, Fiellin, David A.
Publicado 2020

HIV Infection Prevalence Significantly Intersects With COVID-19 Infection At the Area Level: A US County-Level Analysis

por Luan, Hui, Song, Insang, Fiellin, David A., Ransome, Yusuf
Publicado 2021

Association of Poor Mental-Health Days With COVID-19 Infection Rates in the U.S.

por Ransome, Yusuf, Luan, Hui, Song, Insang, Fiellin, David A., Galea, Sandro
Publicado 2022

The Next Therapeutic Challenge in HIV: Polypharmacy

por Edelman, E. Jennifer, Gordon, Kirsha S., Glover, Janis, McNicholl, Ian R., Fiellin, David A., Justice, Amy C.
Publicado 2013

Safety of Gabapentin Prescribed for Any Indication in a Large Clinical Cohort of 571,718 US Veterans with and without Alcohol Use Disorder

por Rentsch, Christopher T., Morford, Kenneth L., Fiellin, David A., Bryant, Kendall J., Justice, Amy C., Tate, Janet P.
Publicado 2020

Naloxone Use by Emergency Medical Services During the COVID-19 Pandemic: A National Survey

por Cone, David C., Bogucki, Sandy, Burns, Kevin, D’Onofrio, Gail, Hawk, Kathryn, Joseph, Daniel, Fiellin, David A.
Publicado 2020

Project ART-ED: alcohol reduction and HIV testing in the emergency department

por Edelman, E Jennifer, Dinh, An, Radu-Radulescu, Lucian, Lurie, Bonnie, Tetrault, Jeanette, D'Onofrio, Gail, Fiellin, David, Fiellin, Lynn
Publicado 2012

Incidence of Precipitated Withdrawal During a Multisite Emergency Department–Initiated Buprenorphine Clinical Trial in the Era of Fentanyl

por D’Onofrio, Gail, Hawk, Kathryn F., Perrone, Jeanmarie, Walsh, Sharon L., Lofwall, Michelle R., Fiellin, David A., Herring, Andrew
Publicado 2023

Primary Care Office-based Buprenorphine Treatment: Comparison of Heroin and Prescription Opioid Dependent Patients

por Moore, Brent A., Fiellin, David A., Barry, Declan T., Sullivan, Lynn E., Chawarski, Marek C., O’Connor, Patrick G., Schottenfeld, Richard S.
Publicado 2007

2224. Receipt and Virologic Outcomes of HCV Direct-Acting Antivirals by Alcohol Use and HIV Status

por Cartwright, Emily J, Rentsch, Christopher T, Esserman, Denise A, Tate, Janet P, Fiellin, David A, Lo Re, Vincent, Justice, Amy C
Publicado 2018

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study

por Larney, Sarah, Hickman, Matthew, Fiellin, David A, Dobbins, Timothy, Nielsen, Suzanne, Jones, Nicola R, Mattick, Richard P, Ali, Robert, Degenhardt, Louisa
Publicado 2018

Computational phenotypes for patients with opioid-related disorders presenting to the emergency department

por Taylor, R. Andrew, Gilson, Aidan, Schulz, Wade, Lopez, Kevin, Young, Patrick, Pandya, Sameer, Coppi, Andreas, Chartash, David, Fiellin, David, D’Onofrio, Gail
Publicado 2023

Patient Satisfaction with Primary Care Office-Based Buprenorphine/Naloxone Treatment

por Barry, Declan T., Moore, Brent A., Pantalon, Michael V., Chawarski, Marek C., Sullivan, Lynn E., O’Connor, Patrick G., Schottenfeld, Richard S., Fiellin, David A.
Publicado 2007

Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report

por Bart, Gavin B., Saxon, Andrew, Fiellin, David A., McNeely, Jennifer, Muench, John P., Shanahan, Christopher W., Huntley, Kristen, Gore-Langton, Robert E.
Publicado 2020

Emergency department‐initiated buprenorphine protocols: A national evaluation

por Guo, Clara Z., D'Onofrio, Gail, Fiellin, David A., Edelman, E. Jennifer, Hawk, Kathryn, Herring, Andrew, McCormack, Ryan, Perrone, Jeanmarie, Cowan, Ethan
Publicado 2021